Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies

T Zang, E Osei Kuffour, VA Baharani… - Proceedings of the …, 2023 - National Acad Sciences
Vaccination will likely be a key component of strategies to curtail or prevent future
sarbecovirus pandemics and to reduce the prevalence of infection and disease by future …

The influence of Omicron on vaccine efficacy and durability: a neurology perspective

JK Muruganantham… - Clinical and Experimental …, 2024 - pmc.ncbi.nlm.nih.gov
Omicron variants present new challenges when it comes to understanding their impact on
vaccines, antiviral strategies, and possible neurological consequences. This article …

Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS‐CoV‐2 Omicron wave: a cross‐sectional survey

M Woldegiorgis, G Cadby, S Ngeh… - Medical Journal of …, 2024 - Wiley Online Library
Objective To estimate the prevalence of long COVID among Western Australian adults, a
highly vaccinated population whose first major exposure to the severe acute respiratory …

Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiological fallacies

JS Morris - American Journal of Epidemiology, 2024 - academic.oup.com
With the emergence of Omicron and establishment of antibody waning over time, vaccine
effectiveness, especially against infection, declined sharply from the original levels seen …

Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals

JS Chwa, M Kim, Y Lee, WA Cheng, Y Shin… - Viruses, 2024 - mdpi.com
Mucosal immunity may contribute to clearing SARS-CoV-2 infection prior to systemic
infection, thereby allowing hosts to remain seronegative. We describe the meaningful …

Retrospective study about clinical severity and epidemiological analysis of the COVID-19 Omicron subvariant lineage-infected patients in Hohhot, China

Y Wang, G Yu, J Shi, X Zhang, J Huo, M Li… - BMC Infectious …, 2024 - Springer
Background Fear of a global public health issue and fresh infection wave in the persistent
COVID-19 pandemic has been enflamed by the appearance of the novel variant Omicron …

[HTML][HTML] Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan

CY Lee, HW Kuo, YL Liu, JH Chuang… - Emerging Infectious …, 2024 - ncbi.nlm.nih.gov
Taiwan provided several COVID-19 vaccine platforms: mRNA (BNT162b2, mRNA-1273),
adenoviral vector-based (AZD1222), and protein subunit (MVC-COV1901). After Taiwan …

Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave-Australia, 2022

M Woldegiorgis, G Cadby, S Ngeh, R Korda… - medRxiv, 2023 - medrxiv.org
Objective: To characterise Long COVID in a highly vaccinated population infected by
Omicron. Design: Follow-up survey of persons testing positive for SARS-CoV-2 in Western …

Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB. 1.5 in Indonesian Residents after Vaccination and Infection

AA Hasyim, A Sakamoto, K Yamagata, KH Zainal… - …, 2024 - pmc.ncbi.nlm.nih.gov
In the post-pandemic era, evaluating long-term immunity against COVID-19 has become
increasingly critical, particularly in light of continuous SARS-CoV-2 mutations. This study …

Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves

K Protopapas, K Thomas, CD Moschopoulos… - …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction: Currently approved SARS-CoV-2 vaccines have been proven effective in
protecting against severe COVID-19; however, they show variable efficacy against …